The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Minocycline prevents the depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons
Abstract
BACKGROUND Our previous study reports the causal role of high mobility group box 1 (HMGB1) in the development of depression; and we find glycyrrhizic acid (GZA) can be a potential treatment for major depressive disorder (MDD) considering its inhibition of HMGB1 activity. This study aims to further explore the exact cell types that release HMGB1 in the hippocampus METHODS: We detected the effects of microglia conditioned medium on primary astrocytes and neurons. The effects of minocycline on depressive-like behaviors were tested in BABLB/c mice after four weeks of chronic unpredictable mild stress (CUMS) exposure. Furthermore, the immunofluorescence (IF) assays, hematoxylin-eosin (HE) and TUNEL staining were used to observe hippocampal slices to evaluate the release of HMGB1. The cytoplasmic translocations of HMGB1 protein were assayed by western-blot RESULTS: Exposure to CUMS caused an active release of HMGB1 from microglia and neurons in the hippocampus. After minocycline administration for inhibiting the activation of microglia, both microglia and neurons reduced the release of HMGB1 and the protein level of central and peripheral HMGB1 recovered accordingly. Along with blocking the release of HMGB1, behavioral and cognitive deficits induced by CUMS were improved significantly by minocycline. In addition, the supernatant of primary microglia stimulated the secretion of HMGB1 in primary neurons, not in astrocytes, at 24 h after 4 h-LPS treatment CONCLUSION: All the evidence supported our hypotheses that microglia and neurons are the main cell sources of HMGB1 release under CUMS condition, and that the release of HMGB1 by microglia may play an important role in the development of depressive-like behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MH, as a tetracycline derivative, exerts anti-inflammatory, neuroprotective, and neurogenesis effects in experimental models of Alzheimer's disease [15], Parkinson's disease [16], depression [17], and neuropathic pain, due to its high lipophilicity and ease of crossing the blood-brain barrier [18].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Reactive Astrocytes: Production, Function, and Therapeutic Potential
Liddelow, S. A., & Barres, B. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.006 · Cited by 2,336
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
Microglial control of astrocytes in response to microbial metabolites
Rothhammer, V., Borucki, D. M., Tjon, E. C., Takenaka, M. C., Chao, C.-C., Ardura-Fabregat, A., de Lima, K. A., Gutiérrez-Vázquez, C., Hewson, P., Staszewski, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0119-x · Cited by 1,051
The Role of Microglia in the Healthy Brain: Figure 1.
Tremblay, M.-È., Stevens, B., Sierra, A., Wake, H., Bessis, A., & Nimmerjahn, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4158-11.2011 · Cited by 992
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Kreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., Maier, S. F., & Yirmiya, R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.155 · Cited by 663
Early-life programming of later-life brain and behavior: a critical role for the immune system
Bilbo, S. D. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.014.2009 · Cited by 652
The Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv082 · Cited by 315
Cognitive remission: a novel objective for the treatment of major depression?
Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252
Hellwig, S., Brioschi, S., Dieni, S., Frings, L., Masuch, A., Blank, T., & Biber, K. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.008 · Cited by 252
Mihm, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103104 · Cited by 232
Weber, M. D., Frank, M. G., Tracey, K. J., Watkins, L. R., & Maier, S. F. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3561-14.2015 · Cited by 215
Herrera-Guzmán, I., Gudayol-Ferré, E., Herrera-Guzmán, D., Guàrdia-Olmos, J., Hinojosa-Calvo, E., & Herrera-Abarca, J. E. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.015 · Cited by 160
Koronyo, Y., Salumbides, B. C., Sheyn, J., Pelissier, L., Li, S., Ljubimov, V., Moyseyev, M., Daley, D., Fuchs, D.-T., Pham, M., et al. (2015) · Brain · doi:10.1093/brain/awv150 · Cited by 153
Executive function improvement upon remission of recurrent unipolar depression
Biringer, E., Lundervold, A., Stordal, K., Mykletun, A., Egeland, J., Bottlender, R., & Lund, A. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0577-7 · Cited by 138
Activated microglia targeting dendrimer–minocycline conjugate as therapeutics for neuroinflammation.
Sharma, R., Kim, S.-Y., Sharma, A., Zhang, Z., Kambhampati, S. P., Kannan, S., & Kannan, R. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00569 · Cited by 100
Persistent non-verbal memory impairment in remitted major depression — Caused by encoding deficits?
Behnken, A., Schöning, S., Gerß, J., Konrad, C., de Jong-Meyer, R., Zwanzger, P., & Arolt, V. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.07.010 · Cited by 79
Research works printed but not linked: 55
- Ajami, 2007, Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nat. Neurosci., 10, 1538, 10.1038/nn2014 · DOI · Paper page
- Avgousti, 2016, A core viral protein binds host nucleosomes to sequester immune danger signals, Nature, 535, 173, 10.1038/nature18317 · DOI
- Balosso, 2014, Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons, Antioxid. Redox Signal., 21, 1726, 10.1089/ars.2013.5349 · DOI · Paper page
- Bhatia, 2017, Alleviation of Microglial Activation Induced by p38 MAPK/MK2/PGE2 Axis by Capsaicin: Potential Involvement of other than TRPV1 Mechanism/s, Sci Rep, 7, 116, 10.1038/s41598-017-00225-5 · DOI
- Capuron, 2011, Immune system to brain signaling: neuropsychopharmacological implications, Pharmacol. Ther., 130, 226, 10.1016/j.pharmthera.2011.01.014 · DOI · Paper page
- Casano, 2015, Microglia: multitasking specialists of the brain, Dev. Cell, 32, 469, 10.1016/j.devcel.2015.01.018 · DOI · Paper page
- Chen, 2004, Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms, J. Leukoc. Biol., 76, 994, 10.1189/jlb.0404242 · DOI · Paper page
- Chen, 2017, Antineuroinflammation of Minocycline in Stroke, The Neurol., 22, 120
- Chen, 2016, Microglia and neuroprotection, J. Neurochem., 136, 10, 10.1111/jnc.13062 · DOI · Paper page
- Cinatl, 2003, Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus, Lancet (London, England), 361, 2045, 10.1016/S0140-6736(03)13615-X · DOI · Paper page
- Cryan, 2005, The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice, Neurosci. Biobehav. Rev., 29, 571, 10.1016/j.neubiorev.2005.03.009 · DOI · Paper page
- Cymerys, J., Chodkowski, M., Slonska, A., Krzyzowska, M., Banbura, M.W., 2019. Disturbances of mitochondrial dynamics in cultured neurons infected with human herpesvirus type 1 and type 2. J Neurovirol. · DOI
- Daulatzai, 2016, Pharmacotherpy and Alzheimer's Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach, Curr. Pharm. Des., 22, 2411, 10.2174/1381612822666160203142111 · DOI
- Ferrini, 2013, Microglia control neuronal network excitability via BDNF signalling, Neural plasticity, 2013, 10.1155/2013/429815 · DOI · Paper page
- Franklin, 2018, Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior, Biol. Psychiatry, 83, 50, 10.1016/j.biopsych.2017.06.034 · DOI · Paper page
- Gao, 2017, Neuroinflammation-Induced Downregulation of Hippocampacal Neuregulin 1-ErbB4 Signaling in the Parvalbumin Interneurons Might Contribute to Cognitive Impairment in a Mouse Model of Sepsis-Associated Encephalopathy, Inflammation, 40, 387, 10.1007/s10753-016-0484-2 · DOI
- Gardella, 2002, The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway, EMBO Rep., 3, 995, 10.1093/embo-reports/kvf198 · DOI · Paper page
- Gong, 2018, Environmental enrichment reduces adolescent anxiety- and depression-like behaviors of rats subjected to infant nerve injury, Journal of neuroinflammation, 15, 262, 10.1186/s12974-018-1301-7 · DOI
- Grippo, 2008, Evaluation of Baroreceptor Reflex Function in the Chronic Mild Stress Rodent Model of Depression, Psychosom. Med., 70, 435, 10.1097/PSY.0b013e31816ff7dd · DOI
- Harry, 2008, Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment, Expert Opin. Drug Metab. Toxicol., 4, 1265, 10.1517/17425255.4.10.1265 · DOI · Paper page
- Kalinina, 2004, Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines, Arterioscler. Thromb. Vasc. Biol., 24, 2320, 10.1161/01.ATV.0000145573.36113.8a · DOI · Paper page
- Keyel, 2014, How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1, Cytokine, 69, 136, 10.1016/j.cyto.2014.03.007 · DOI · Paper page
- Kim, 2018, Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options, Clin. Psychopharmacol. Neurosci Off. Scient. J. Korean College Neuropsychopharmacol., 16, 246, 10.9758/cpn.2018.16.3.246 · DOI
- Lehnardt, 2010, Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury, Glia, 58, 253, 10.1002/glia.20928 · DOI · Paper page
- Li, 2014, Glycyrrhizic acid in the treatment of liver diseases: literature review, Biomed Res. Int., 2014
- Lian, 2017, Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1, Brain Behav. Immun., 59, 322, 10.1016/j.bbi.2016.09.017 · DOI
- Liu, 2015, TNFalpha mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress, Eur. Cytokine Netw., 26, 15, 10.1684/ecn.2015.0362 · DOI
- Lotze, 2005, High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal, Nat. Rev. Immunol., 5, 331, 10.1038/nri1594 · DOI · Paper page
- Lu, 2014, JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation, PNAS, 111, 3068, 10.1073/pnas.1316925111 · DOI · Paper page
- Lutz, 2015, The Dietary Flavonoid Rhamnetin Inhibits Both Inflammation and Excitotoxicity During Ethanol Withdrawal in Rat Organotypic Hippocampal Slice Cultures, Alcohol Clin Exp Res, 39, 2345, 10.1111/acer.12896 · DOI
- Magna, 2014, The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases, Mol. Med., 20, 138, 10.2119/molmed.2013.00164 · DOI · Paper page
- Mazarati, 2011, High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products, Exp. Neurol., 232, 143, 10.1016/j.expneurol.2011.08.012 · DOI · Paper page
- Naderi, 2017, Neuroprotective effect of minocycline on cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory and anti-oxidant properties in male rat, Brain Res. Bull., 131, 207, 10.1016/j.brainresbull.2017.04.010 · DOI
- Peng, 2012, Inducible nitric oxide synthase is involved in the modulation of depressive behaviors induced by unpredictable chronic mild stress, J. Neuroinflamm., 9, 75, 10.1186/1742-2094-9-75 · DOI
- Piotrowska, 2017, Comparison of the Expression Changes after Botulinum Toxin Type A and Minocycline Administration in Lipopolysaccharide-Stimulated Rat Microglial and Astroglial Cultures, Front Cell Infect Microbiol, 7, 141, 10.3389/fcimb.2017.00141 · DOI
- Popovich, 2011, Momordica charantia seed extract reduces pre-adipocyte viability, affects lactate dehydrogenase release, and lipid accumulation in 3T3-L1 cells, J. Med. Food, 14, 201, 10.1089/jmf.2010.1150 · DOI
- Qiu, 2008, Early release of HMGB-1 from neurons after the onset of brain ischemia, J. Cerebr. Blood Flow Metabol. Off. J. Int. Soc. Cerebr. Blood Flow Metabol., 28, 927, 10.1038/sj.jcbfm.9600582 · DOI · Paper page
- Regen, 2016, Inhibition of brain retinoic acid catabolism: a mechanism for minocycline's pleiotropic actions?, World J. Biol. Psychiat. Off. J. World Federat. Societies Biol. Psychiat., 17, 634
- Rosenblat, 2018, Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials, J. Affect. Disord., 227, 219, 10.1016/j.jad.2017.10.042 · DOI · Paper page
- Rosenfeld, 2014, Barnes maze testing strategies with small and large rodent models, J. Visual. Exp. JoVE, 10.3791/51194-v · doi:10.3791/51194-v · Paper page
- Song, 2018, MiR-212 Attenuates MPP(+)-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells, Yonsei Med. J., 59, 416, 10.3349/ymj.2018.59.3.416 · DOI
- Speciale, 1990, Uptake of kynurenine into rat brain slices, J. Neurochem., 54, 156, 10.1111/j.1471-4159.1990.tb13296.x · DOI
- Su, 2017, Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance, J. Neuroinflamm., 14, 210, 10.1186/s12974-017-0985-4 · DOI
- Tong, 2017, Microglia Loss Contributes to the Development of Major Depression Induced by Different Types of Chronic Stresses, Neurochem. Res., 42, 2698, 10.1007/s11064-017-2270-4 · DOI
- Tsung, 2005, The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion, J. Exp. Med., 201, 1135, 10.1084/jem.20042614 · DOI · Paper page
- Valibeigi, 2018, A Modified Barnes Maze for Juvenile Rats, Bio-protocol, 8
- Wang, 2018, Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect, Behav. Brain Res., 353, 250, 10.1016/j.bbr.2018.01.024 · DOI
- Wang, 2019, FrHMGB1 and dsHMGB1 activate the kynurenine pathway via different mechanisms in association with depressivelike behavior, Mol. Med. Rep., 20, 359
- Wang, 2018, HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway, Brain Behav. Immun., 72, 51, 10.1016/j.bbi.2017.11.017 · DOI
- Wang, 2010, LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia, Brain Behav. Immun., 24, 201, 10.1016/j.bbi.2009.06.152 · DOI
- Wu, 2015, High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior, J. Psychiatr. Res., 64, 99, 10.1016/j.jpsychires.2015.02.016 · DOI
- Yang, F., Zhu, W., Cai, X., Zhang, W., Yu, Z., Li, X., Zhang, J., Cai, M., Xiang, J., Cai, D., 2020. Minocycline alleviates NLRP3 inflammasome-dependent pyroptosis in monosodium glutamate-induced depressive rats. Biochemical and biophysical research communications. · DOI
- Zhang, 2018, Switching of the Microglial Activation Phenotype Is a Possible Treatment for Depression Disorder, Front. Cell. Neurosci., 12, 306, 10.3389/fncel.2018.00306 · DOI · Paper page
- Zhang, 2015, NLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation, Int. J. Neuropsychopharmacol., 18, 10.1093/ijnp/pyv006 · DOI · Paper page
- Zhou, 2014, A dual-role of Gu-4 in suppressing HMGB1 secretion and blocking HMGB1 pro-inflammatory activity during inflammation, PLoS ONE, 9
Cited by
The mechanism of HMGB1 secretion and release
Chen, R., Kang, R., & Tang, D. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00736-w · Cited by 849
Yin, X.-Y., Tang, X.-H., Wang, S.-X., Zhao, Y.-C., Jia, M., Yang, J.-J., Ji, M.-H., & Shen, J.-C. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02756-3 · Cited by 138
Hellmann-Regen, J., Clemens, V., Grözinger, M., Kornhuber, J., Reif, A., Prvulovic, D., Goya-Maldonado, R., Wiltfang, J., Gruber, O., Schüle, C., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.30367 · Cited by 100
Moriyama, N., Saito, M., Ono, Y., Yamashita, K., Aoi, T., & Kotani, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134309 · Cited by 7
Guo, Q., Wang, Y., Fu, M., Zhou, Z., Zhang, X., Chen, S., Xu, C., Wang, Y., & Wu, T. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102309 · Cited by 1
Self-citation
Metadata
- Authors
- Wang, B., Huang, X., Pan, X., Zhang, T., Hou, C., Su, W.-J., Liu, L.-L., Li, J.-M., & Wang, Y.-X.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 88
- Pages
- 132-143
- ISSN
- 0889-1591
- Cited by
- 129
- References
- 29
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- National Natural Science Foundation of China (81171124, 81771301)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.